The A2ALL consortium was chartered in 2002 and has collected data on a large cohort of donor and recipient candidates for LDLT spanning over a decade of activity in 9 US centers. Dr. Emond has been a Co-chair of A2ALL and a member of the Project Executive Committee since the onset of the study and led the development of the cohort protocol. The consortium has contributed important publications defining the benefit of choosing living donation, and the outcomes and complications of the donor and recipient procedure. Descriptive studies from the retrospective cohort have defined the donor evaluation, and illuminated important issues on hepatitis C, HCC, and rejection in recipients of LDLT. A2ALL remains positioned to address critical biological questions related to hepatic inflammation, regeneration, and carcinogenesis in the recipient. A novel and important interventional trial of pre-transplant treatment of HCV in LDLT candidates is underway. Equally important is to study donor liver function and regeneration as well as to define the long-term medical and psychological consequences of liver donation. Columbia has contributed substantially to the overall accrual of A2ALL includes 239 subjects in retro, 17 subjects in bridge and 270 in A2ALL cohort. Clinical outcomes are excellent with a one year recipient survival of 95.3% of adults. In this application for renewal, we commit to continued follow-up of our donors and recipients and further accrual of subjects to achieve the goals of the consortium as defined in the RFA. We describe numerous organizational and technologic improvements in our center, including dedicated staff and an electronic record system to optimize data collection and follow-up. Though A2ALL has made great progress in description of LDLT and defining the outcomes, we have fallen short in two critical areas, understanding of the donor experience and development of surgical innovations to reduce the donor operation without compromising recipient outcomes. These related issues are central to making the case for expansion of LDLT in adults. No matter how good the results of LDLT, there will be no impact if it is not used. To this end we introduce two research proposals that are complementary and enhance the overall aims of A2ALL. First, a structured study of the psychiatric complications in living donors including developing predictors and determining using a control population of concurrently enrolled laparoscopic renal donors whether more limited hepatectomy will improve psychological health of donors. Second, a pilot protocol of using smaller left lobe grafts with appropriate biological and technical manipulations

Public Health Relevance

There remains a major shortage of donors for the nearly 16000 patients waiting for liver transplantation (OLT). Living donor liver transplantation (LDLT) has offered an alternative source of organs but was used in only 178 of 5705 adults (3.1%) receiving OLT in the US in 2008. We propose to increase the use of LDLT by interventions which decrease the extent of the donor hepatectomy, increasing donor safety

National Institute of Health (NIH)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Sherker, Averell H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
Schools of Medicine
New York
United States
Zip Code
Terrault, Norah A; Stravitz, R Todd; Lok, Anna S F et al. (2014) Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study. Hepatology 59:1311-9
Brown Jr, Robert S; Smith, Abigail R; Dew, Mary Amanda et al. (2014) Predictors of donor follow-up after living donor liver transplantation. Liver Transpl 20:967-76
Everson, Gregory T; Hoefs, John C; Niemann, Claus U et al. (2013) Functional elements associated with hepatic regeneration in living donors after right hepatic lobectomy. Liver Transpl 19:292-304
Everson, Gregory T; Terrault, Norah A; Lok, Anna S et al. (2013) A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation. Hepatology 57:1752-62
Freeman, Jason; Emond, Jean; Gillespie, Brenda W et al. (2013) Computerized assessment of competence-related abilities in living liver donors: the Adult-to-Adult Living Donor Liver Transplantation Cohort Study. Clin Transplant 27:633-45
Zimmerman, Michael A; Baker, Talia; Goodrich, Nathan P et al. (2013) Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium. Liver Transpl 19:259-67
Abecassis, M M; Fisher, R A; Olthoff, K M et al. (2012) Complications of living donor hepatic lobectomy--a comprehensive report. Am J Transplant 12:1208-17
Olthoff, Kim M; Abecassis, Michael M; Emond, Jean C et al. (2011) Outcomes of adult living donor liver transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience. Liver Transpl 17:789-97
Trotter, James F; Gillespie, Brenda W; Terrault, Norah A et al. (2011) Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl 17:409-17
Gillespie, B W; Merion, R M; Ortiz-Rios, E et al. (2010) Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant 10:1621-33

Showing the most recent 10 out of 22 publications